PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 207 filers reported holding PORTOLA PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 1.78 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $2,130,000 | +159.4% | 118,398 | +2.8% | 0.00% | +100.0% |
| Q1 2020 | $821,000 | -70.5% | 115,152 | -1.1% | 0.00% | -60.0% |
| Q4 2019 | $2,781,000 | -11.0% | 116,452 | +0.0% | 0.01% | -16.7% |
| Q3 2019 | $3,123,000 | +12.1% | 116,442 | +13.3% | 0.01% | +20.0% |
| Q2 2019 | $2,787,000 | -19.4% | 102,740 | +3.1% | 0.01% | -28.6% |
| Q1 2019 | $3,459,000 | +73.7% | 99,697 | -2.2% | 0.01% | +40.0% |
| Q4 2018 | $1,991,000 | -25.2% | 101,984 | +2.0% | 0.01% | 0.0% |
| Q3 2018 | $2,661,000 | -29.3% | 99,943 | +0.3% | 0.01% | -37.5% |
| Q2 2018 | $3,764,000 | +33.1% | 99,651 | +15.1% | 0.01% | +33.3% |
| Q1 2018 | $2,828,000 | -35.2% | 86,586 | -3.4% | 0.01% | -33.3% |
| Q4 2017 | $4,363,000 | -8.6% | 89,622 | +1.4% | 0.01% | -18.2% |
| Q3 2017 | $4,776,000 | -3.4% | 88,398 | +0.4% | 0.01% | 0.0% |
| Q2 2017 | $4,946,000 | +30.1% | 88,055 | -9.2% | 0.01% | +37.5% |
| Q1 2017 | $3,801,000 | +66.9% | 96,991 | -4.4% | 0.01% | +60.0% |
| Q4 2016 | $2,277,000 | -3.8% | 101,491 | -2.7% | 0.01% | 0.0% |
| Q3 2016 | $2,368,000 | -2.9% | 104,291 | +1.0% | 0.01% | 0.0% |
| Q2 2016 | $2,438,000 | +13.0% | 103,291 | -2.3% | 0.01% | 0.0% |
| Q1 2016 | $2,157,000 | -54.7% | 105,715 | +14.3% | 0.01% | -58.3% |
| Q4 2015 | $4,759,000 | +32.5% | 92,491 | +9.7% | 0.01% | +33.3% |
| Q3 2015 | $3,592,000 | -6.6% | 84,282 | -0.1% | 0.01% | 0.0% |
| Q2 2015 | $3,844,000 | +20.4% | 84,382 | +0.3% | 0.01% | +12.5% |
| Q1 2015 | $3,193,000 | +41.7% | 84,103 | +5.7% | 0.01% | +60.0% |
| Q4 2014 | $2,254,000 | +31.0% | 79,603 | +16.9% | 0.01% | +25.0% |
| Q3 2014 | $1,721,000 | -12.5% | 68,066 | +1.0% | 0.00% | -20.0% |
| Q2 2014 | $1,966,000 | +284.0% | 67,379 | +240.7% | 0.01% | +400.0% |
| Q1 2014 | $512,000 | +0.6% | 19,779 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $509,000 | +10.2% | 19,779 | +14.5% | 0.00% | 0.0% |
| Q3 2013 | $462,000 | +11.3% | 17,279 | +2.4% | 0.00% | 0.0% |
| Q2 2013 | $415,000 | – | 16,879 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fernwood Investment Management, LLC | 228,873 | $7,475,000 | 4.17% |
| PFM Health Sciences, LP | 5,326,671 | $173,969,000 | 3.54% |
| Marcus Capital, LLC | 22,950 | $750,000 | 2.76% |
| Partner Investment Management, L.P. | 72,284 | $2,361,000 | 2.55% |
| CADIAN CAPITAL MANAGEMENT, LP | 1,240,944 | $40,529,000 | 2.19% |
| HARVEY CAPITAL MANAGEMENT INC | 158,580 | $5,179,000 | 1.94% |
| SECTORAL ASSET MANAGEMENT INC | 498,412 | $16,278,000 | 1.78% |
| Everett Capital Advisors UK LLP | 551,173 | $18,001,000 | 1.52% |
| ROSENBLUM SILVERMAN SUTTON S F INC /CA | 125,210 | $4,089,000 | 1.46% |
| Atika Capital Management LLC | 113,000 | $3,691,000 | 1.26% |